Combination of biomarkers reflecting type IV collagen degradation and citrullinated vimentin predicts response to adalimumab with high diagnostic accuracy, in patients with Crohn's disease

Joachim Høg Mortensen  1     Morten Asser Karsdal  1     Henning Grønbæk  2     Christian Lodberg Hvas  2     Anders Dige  2     Tina Manon-Jensen  1    
1 Nordic Bioscience,Herlev,Denmark
2 Aarhus University Hospital,Aarhus,Denmark

UEG Week 2019

United European Gastroenterology Journal Volume 7 Issue 8 (Supplement), October 2019

Login to access library content


Do you need help setting up your myUEG account?
Contact us at

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing